By the year 2032, the projected value of the non-hyaluronic acid dermal filler industry is set to soar to an impressive US$520.4 million. FMI Analysts report that the global non-hyaluronic acid dermal filler market, which stood at US$392.7 million in 2022, is poised for a steady growth trajectory with a 2.6% CAGR expected from 2022 to 2032.
Hyaluronic acid (HA), a natural skin hydrator and plumper, has long been favored for dermal filler treatments. However, an increasing number of individuals, either due to HA allergies or a desire for more enduring outcomes, are fueling the rising demand for non-HA fillers.
Claim your complimentary report with captivating visuals.
https://www.futuremarketinsights.com/reports/sample/rep-gb-5699
Non-HA dermal fillers are made from a variety of materials, including calcium hydroxylapatite (CaHA), poly-L-lactic acid (PLLA), and polymethylmethacrylate (PMMA). CaHA fillers are the most common type of non-HA filler and are typically used to add volume to the cheeks, chin, and jawline. PLLA and PMMA fillers are longer-lasting than CaHA fillers and are often used to treat wrinkles and furrows.
The non-HA several factors, including, is driving the dermal filler market:
- Increasing demand for non-surgical cosmetic procedures
- Growing awareness of non-HA fillers among consumers
- Rising disposable incomes in developing countries
- Technological advancements in the development of new non-HA fillers
These companies are investing heavily in research and development to develop new and innovative non-HA fillers. For example, Merz Aesthetics recently launched Radiesse Volumizing Filler, a new CaHA filler that is designed to provide long-lasting volume and correction to the midface region.
The non-HA dermal filler market is expected to continue to grow in the coming years. This group is being driven by the increasing demand for non-surgical cosmetic procedures and the growing awareness of non-HA fillers among consumers.
Key Takeaways:
- The global non-hyaluronic acid dermal filler market is expected to grow at a CAGR of 2.6% from 2022 to 2032.
- The growth of the market is attributed to several factors, including increasing demand for non-invasive cosmetic procedures, rising awareness of the benefits of non-hyaluronic acid dermal fillers, growing geriatric population, and increasing disposable incomes.
- Non-hyaluronic acid dermal fillers offer several advantages over HA fillers, including longer-lasting results, less risk of allergic reactions, and greater versatility.
- The most common types of non-hyaluronic acid dermal fillers include calcium hydroxylapatite (CaHA), polymethylmethacrylate (PMMA), and poly-lactic acid (PLLA).
- The non-hyaluronic acid dermal filler market is expected to be driven by the growing demand for non-invasive cosmetic procedures.
Click to Access Methodology!
https://www.futuremarketinsights.com/request-report-methodology/rep-gb-5699
Key Companies Profiled:
- Allergan, Inc.
- Galderma SA
- Merz Pharma GmbH & Co.
- KGaA, Suneva Medical Inc.
- Specialty European Pharma
- Sinclair Pharma
- Valeant Pharmaceuticals International Inc.
- LifeCell Corporation
- Dr. Korman Laboratories Ltd.
- ForeverInject International Holdings Co. Limited.
Key Segments Profiled in the Non-Hyaluronic Acid Dermal Filler Market
By Product Type:
- Collagen
- Hydroxylapatite
- Polylactic Acid
- Polyalkylimide
- Polymethyl-Methacrylate Microspheres
By Application:
- Aesthetic Volume Restoration
- Wrinkle Reduction
Tap into Comprehensive Segmented Information – Purchase Now!
https://www.futuremarketinsights.com/checkout/5699
By Region:
- North America
- Latin America
- Western Europe
- Eastern Europe
- Asia-Pacific
- Japan
- Middle East and Africa
Author
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5,000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube